Skip to main content
OpenTrials
Completed

NCT Number: NCT05054205

Motivational Interview-based Self-management Training

Chronic Obstructive Pulmonary Disease (COPD) is an important chronic disease that causes increasing mortality and morbidity globally, as well as a social and economic burden. All symptoms (cough, sputum production, etc.), especially dyspnea in COPD, the chronicity of the disease and the need for long-term care limit the lives of the patients. Dyspnea occurring in COPD negatively affects the self-confidence of patients by restricting their activities of daily living, thus causing a decrease in their self-efficacy levels. Low self-efficacy levels cause patients to limit their activities more.

Nurses play an important role in ensuring the management of COPD, supporting patients to continue their activities of daily living, and increasing their self-efficacy levels. Nursing care that includes patient education and counseling is important in providing disease management and symptom control, and increasing the self-efficacy levels of patients. During self-management training, it is necessary to ensure that the patient is an active participant, to use a motivating communication style in the behavior change process and to encourage patients. In this process, it is stated that it is important to use motivational interview techniques in self-management training given by nurses.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Chronic Disease Disease Attributes Lung Diseases Lung Diseases, Obstructive Motivational Interviewing Pathologic Processes Pathological Conditions, Signs and Symptoms Psychiatric Nursing Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Self Management Self-Efficacy

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Denizli Buldan Chest Diseases Hospital

Denizli, Buldan, 20400, Turkey (Türkiye)

About this study

This study was conducted to investigate the effect on self-efficacy of self-management education and motivational interview among COPD patients. This randomized controlled experimental study was conducted between March and May 2018 with 39 intervention and 39 control groups, a total of 78 patients in the Chest Diseases Clinic of Chest Diseases Hospital who were treated with COPD. In data collection; ''Patient Data Form'', ''Medical Research Council (MRC) Dyspnea Scale'', ''COPD Self Efficacy Scale (CSES)'' were used. To the experimental group; motivational interview based self-management education was given for 30-45 minutes with groups of 5-8 people, COPD education guide was given, questions were shared with the question-answer method and group interaction was provided. After the self-management education, 3 motivational interviews were conducted 3 days apart with 30-45 minutes. Normal care was continued in the control group. The data were collected in three stages as pre-test, post-test and follow-up. According to the research ethics, self-management education and COPD education guidelines were given to the control group and motivational interviews were conducted. In this study, written consent was obtained from the ethics committee, institutions and patients.

  • Self-efficacy levels and dyspnea perception levels of COPD patients are the dependent variables of the study.
  • Self-management training and motivational interviewing given to COPD patients are the independent variables of the research.
  • Control variables of the study; age, gender, marital status, education status, occupation, employment status, smoking status, duration of being a COPD patient, number of hospitalizations, drug use status, people living with at home, type of warming, participation in COPD education and Pulmonary Rehabilitation program.
  • H0: Self-management training and motivational interviewing given to COPD patients have no effect on self-efficacy and dyspnea perception.
  • H1: Self-management training and motivational interviewing given to COPD patients have an effect on self-efficacy and dyspnea perception.
  • All statistical analyzes were made SPSS 25 package program. The obtained data were analyzed by means of percentage distributions, mean, variance analysis in repeated measures, bonferroni analysis as a further analysis and t test in dependent groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • To receive inpatient treatment with the diagnosis of COPD,
  • To be literate,
  • To have the cognitive and mental competence to answer questions,
  • Disease symptoms are at a level that does not prevent communication

Exclusion criteria

  • The patient is in an acute exacerbation period,
  • Having dyspnea at a level that prevents cooperation,
  • Presence of sensory loss related to vision, hearing and speech,
  • Presence of cognitive and mental impairment that prevents communication

Treatment and study plan

Motivational İnterviewing

Behavioral

The most current version of Motivational İnterviewing (MI) is described in detail in Miller and Rollnick (2013) Motivational Interviewing: Helping people to change (3rd edition). Key qualities include:

MI is a guiding style of communication, that sits between following (good listening) and directing (giving information and advice).

MI is designed to empower people to change by drawing out their own meaning, importance and capacity for change.

MI is based on a respectful and curious way of being with people that facilitates the natural process of change and honors client autonomy.

Other names: Self- management training

Primary outcomes

  1. Self Efficacy

    Time frame: measuring self-efficacy levels at baseline

    COPD Self Efficacy Scale: The scale is composed of 34 items. It is a five-point Likert scale; one corresponds to 'I am not confident' (not efficacious), two 'I am a little confident' (efficacious), three 'I am confident to some extent' (efficacious), four 'I am quite confident' (efficacious) and 5 'I am very confident' (efficacious). The highest and lowest scores for the scale are 170 and 34, respectively. An increase in the self-efficacy scale mean score indicates that the patient's self-efficacy level has improved. Total or mean scores for the scale and its subscales are utilized for the evaluation of self-efficacy in patients with COPD.

  2. Self Efficacy

    Time frame: Change in self-efficacy level immediately after completion of a two-week motivational interview-based self-management training

    COPD Self Efficacy Scale: The scale is composed of 34 items. It is a five-point Likert scale; one corresponds to 'I am not confident' (not efficacious), two 'I am a little confident' (efficacious), three 'I am confident to some extent' (efficacious), four 'I am quite confident' (efficacious) and 5 'I am very confident' (efficacious). The highest and lowest scores for the scale are 170 and 34, respectively. An increase in the self-efficacy scale mean score indicates that the patient's self-efficacy level has improved. Total or mean scores for the scale and its subscales are utilized for the evaluation of self-efficacy in patients with COPD.

  3. Self Efficacy

    Time frame: Change in self-efficacy level one month after motivational interview-based self-management training

    COPD Self Efficacy Scale: The scale is composed of 34 items. It is a five-point Likert scale; one corresponds to 'I am not confident' (not efficacious), two 'I am a little confident' (efficacious), three 'I am confident to some extent' (efficacious), four 'I am quite confident' (efficacious) and 5 'I am very confident' (efficacious). The highest and lowest scores for the scale are 170 and 34, respectively. An increase in the self-efficacy scale mean score indicates that the patient's self-efficacy level has improved. Total or mean scores for the scale and its subscales are utilized for the evaluation of self-efficacy in patients with COPD.

Secondary outcomes

  1. Perception of dyspnea

    Time frame: Measuring perception of dyspnea levels at baseline

    Medical Research Council Dyspnea Scale: The Medical Research Council Dyspnea Scale is a 0-4 point category scale in which one of five expressions related to the perception of dyspnea is selected to best describe the patient's dyspnea level. ''0 points'' no dyspnea ''4 points'' indicates very severe dyspnea.

  2. Perception of dyspnea

    Time frame: Change in perception of dyspnea level immediately after completion of a two-week motivational interview-based self-management program

    Medical Research Council Dyspnea Scale: The Medical Research Council Dyspnea Scale is a 0-4 point category scale in which one of five expressions related to the perception of dyspnea is selected to best describe the patient's dyspnea level. ''0 points'' no dyspnea ''4 points'' indicates very severe dyspnea.

  3. Perception of dyspnea

    Time frame: Change in perception of dyspnea level one month after motivational interview-based self-management training

    Medical Research Council Dyspnea Scale: The Medical Research Council Dyspnea Scale is a 0-4 point category scale in which one of five expressions related to the perception of dyspnea is selected to best describe the patient's dyspnea level. ''0 points'' no dyspnea ''4 points'' indicates very severe dyspnea.

Sponsors and collaborators

Lead sponsor

Akdeniz University

Other

Collaborators

  • Aydin Adnan Menderes University

Registry information

Official study title

The Effect on Self-effıcacy of Self-management Program Based on motıvatıonal ıntervıewing in Chronic Obstructive Pulmonary Disease (COPD) patıents: A Randomized Controlled Trial

Acronym: COPD

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
Sep 23, 2021
Registry last updated
Sep 23, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.